206 related articles for article (PubMed ID: 24928123)
1. Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs.
Thaler DE; Ruthazer R; Weimar C; Mas JL; Serena J; Di Angelantonio E; Papetti F; Homma S; Mattle HP; Nedeltchev K; Mono ML; Jaigobin C; Michel P; Elkind MS; Di Tullio MR; Lutz JS; Griffith J; Kent DM
Neurology; 2014 Jul; 83(3):221-6. PubMed ID: 24928123
[TBL] [Abstract][Full Text] [Related]
2. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
3. Cardiac and Echocardiographic Markers in Cryptogenic Stroke with Incidental Patent Foramen Ovale.
Tateishi Y; Ueno Y; Tsujino A; Kuriki A; Kamiya Y; Shimizu T; Doijiri R; Yamaguchi E; Kikuno M; Shimada Y; Takekawa H; Koga M; Ihara M; Hirata K; Hasegawa Y; Toyoda K; Hattori N; Urabe T;
J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105892. PubMed ID: 34107415
[TBL] [Abstract][Full Text] [Related]
4. Comparison of atrial septal defect and patent foramen ovale in cryptogenic strokes.
Delabays C; Correia P; Eeckhout E; Delabays A; Michel P
J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107664. PubMed ID: 38428550
[TBL] [Abstract][Full Text] [Related]
5. Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
Strambo D; Sirimarco G; Nannoni S; Perlepe K; Ntaios G; Vemmos K; Michel P
Stroke; 2021 May; 52(5):1643-1652. PubMed ID: 33784832
[TBL] [Abstract][Full Text] [Related]
6. The Risk of Paradoxical Embolism (RoPE) Study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke.
Kent DM; Thaler DE;
Trials; 2011 Jul; 12():185. PubMed ID: 21794121
[TBL] [Abstract][Full Text] [Related]
7. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.
Wessler BS; Thaler DE; Ruthazer R; Weimar C; Di Tullio MR; Elkind MS; Homma S; Lutz JS; Mas JL; Mattle HP; Meier B; Nedeltchev K; Papetti F; Di Angelantonio E; Reisman M; Serena J; Kent DM
Circ Cardiovasc Imaging; 2014 Jan; 7(1):125-31. PubMed ID: 24214884
[TBL] [Abstract][Full Text] [Related]
8. The RoPE Score and Right-to-Left Shunt Severity by Transcranial Doppler in the CODICIA Study.
Wessler BS; Kent DM; Thaler DE; Ruthazer R; Lutz JS; Serena J
Cerebrovasc Dis; 2015; 40(1-2):52-8. PubMed ID: 26184495
[TBL] [Abstract][Full Text] [Related]
9. Clinical RoPE (cRoPE) score predicts patent foramen ovale detection among stroke patients: a multicenter observational study.
Giannandrea D; Padiglioni C; Eusebi P; Mengoni A; Romoli M; Galati F; Vecchio A; Cenciarelli S; Ricci S; Consoli D;
Neurol Sci; 2020 Nov; 41(11):3227-3233. PubMed ID: 32388644
[TBL] [Abstract][Full Text] [Related]
10. The risk of paradoxical embolism (RoPE) study: initial description of the completed database.
Thaler DE; Di Angelantonio E; Di Tullio MR; Donovan JS; Griffith J; Homma S; Jaigobin C; Mas JL; Mattle HP; Michel P; Mono ML; Nedeltchev K; Papetti F; Ruthazer R; Serena J; Weimar C; Elkind MS; Kent DM
Int J Stroke; 2013 Dec; 8(8):612-9. PubMed ID: 22883936
[TBL] [Abstract][Full Text] [Related]
11. Recurrent events after percutaneous closure of patent foramen ovale.
Wallenborn J; Bertog SC; Franke J; Steinberg DH; Majunke N; Wilson N; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2013 Oct; 82(4):541-6. PubMed ID: 22707325
[TBL] [Abstract][Full Text] [Related]
12. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis.
Ntaios G; Papavasileiou V; Makaritsis K; Michel P
Int J Cardiol; 2013 Oct; 169(2):101-5. PubMed ID: 24041984
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure.
Ateş AH; Yorgun H; Canpolat U; Şener YZ; Okşul M; Kaya EB; Şahiner ML; Topcuoğlu MA; Arsava EM; Aytemir K
Turk Kardiyol Dern Ars; 2021 Jan; 49(1):29-39. PubMed ID: 33390571
[TBL] [Abstract][Full Text] [Related]
14. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
15. Study of Transesophageal Echocardiography in Young Patients with Cryptogenic Stroke: Prevalence of Patent Foramen Ovale and Interpretation of the RoPE Score.
Arslan A; Yılmaz DÇ; Adıyaman M; Kara C; Örsçelik Ö; Yılmaz IA
Turk Kardiyol Dern Ars; 2022 Jul; 50(5):314-319. PubMed ID: 35860882
[TBL] [Abstract][Full Text] [Related]
16. Sustained risk of recurrent thromboembolic events in patients with patent foramen ovale and paradoxical embolism: long-term follow-up over more than 15 years.
Fischer D; Gardiwal A; Haentjes J; Klein G; Meyer GP; Drexler H; Hausmann D; Schaefer A
Clin Res Cardiol; 2012 Apr; 101(4):297-303. PubMed ID: 22159895
[TBL] [Abstract][Full Text] [Related]
17. Potential Embolic Sources in Embolic Stroke of Undetermined Source Patients with Patent Foramen Ovale.
Toh KZX; Koh MY; Ho JSY; Ong KHX; Lee YQ; Chen X; Fang JT; Chong EY; Lim ICZY; Teo YH; Teo YN; Chua CYK; Lim Y; Chan BPL; Sharma VK; Yeo LLL; Sia CH; Tan BYQ
Cerebrovasc Dis; 2023; 52(5):503-510. PubMed ID: 36455524
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review.
Mazzucco S; Li L; Rothwell PM
JAMA Neurol; 2020 Oct; 77(10):1279-1287. PubMed ID: 32628255
[TBL] [Abstract][Full Text] [Related]
20. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke.
Kent DM; Ruthazer R; Weimar C; Mas JL; Serena J; Homma S; Di Angelantonio E; Di Tullio MR; Lutz JS; Elkind MS; Griffith J; Jaigobin C; Mattle HP; Michel P; Mono ML; Nedeltchev K; Papetti F; Thaler DE
Neurology; 2013 Aug; 81(7):619-25. PubMed ID: 23864310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
